Sensei Biotherapeutics (NASDAQ:FTH) Research Coverage Started at TD Cowen
TD Cowen assumed coverage on shares of Sensei Biotherapeutics (NASDAQ:FTH – Free Report) in a report published on Wednesday, MarketBeat.com reports. The firm issued a buy rating on the stock. FTH has been the topic of a number of other research reports. Citigroup assumed coverage on shares of Sensei Biotherapeutics in a research report on […]
Collegium Pharmaceutical (NASDAQ:COLL) Research Coverage Started at Leerink Partners
Leerink Partners assumed coverage on shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) in a research report sent to investors on Wednesday, Marketbeat.com reports. The brokerage issued an outperform rating and a $45.00 target price on the specialty pharmaceutical company’s stock. Other research analysts also recently issued research reports about the stock. Zacks Research downgraded […]
Nautilus Biotechnology (NASDAQ:NAUT) Research Coverage Started at Leerink Partners
Leerink Partners started coverage on shares of Nautilus Biotechnology (NASDAQ:NAUT – Free Report) in a research note released on Wednesday, MarketBeat.com reports. The brokerage issued an outperform rating and a $4.00 price target on the stock. Separately, Weiss Ratings downgraded Nautilus Biotechnology from a “sell (d-)” rating to a “sell (e+)” rating in a research […]
Invesco (NYSE:IVZ) Research Coverage Started at Keefe, Bruyette & Woods
Keefe, Bruyette & Woods started coverage on shares of Invesco (NYSE:IVZ – Free Report) in a report published on Wednesday morning, MarketBeat.com reports. The brokerage issued an outperform rating and a $39.00 target price on the asset manager’s stock. A number of other research analysts have also commented on IVZ. Morgan Stanley boosted their price […]
last updated on 12 Sep 08:51